Announcements Trials

Browse Landscape

Phase

Phase 4 4 Phase 2 2 Phase NA 1 Phase 3 1 Phase 1 1

Status

Completed 3 Terminated 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 145 Carcinoma, Non-Small-Cell Lung 97 Colorectal Neoplasms 96 Carcinoma, Hepatocellular 69 Stomach Neoplasms 65 Rectal Neoplasms 54 Neoplasms 53 Lung Neoplasms 44 Prostatic Neoplasms 41 Colonic Neoplasms 41 Leukemia, Myeloid, Acute 40 Nasopharyngeal Carcinoma 39 Lymphoma, Large B-Cell, Diffuse 39 Uterine Cervical Neoplasms 37 Esophageal Neoplasms 33 Ovarian Neoplasms 32 Neoplasm Metastasis 32 Multiple Myeloma 31 Lymphoma 31 Lymphoma, Follicular 30 Leukemia 28 Pancreatic Neoplasms 27 Recurrence 23 Head and Neck Neoplasms 22 Brain Neoplasms 21 Urinary Bladder Neoplasms 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Lymphoma, Non-Hodgkin 19 Lymphoma, Mantle-Cell 18 Squamous Cell Carcinoma of Head and Neck 17

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Hepatitis B × Clear all

NCT02186574 2019-12-12

Tenofovir to Prevent HBV Reactivation

University Health Network, Toronto

Phase 3 Unknown

Hepatitis B, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡